OTC ORAL CONTRACEPTIVE BENEFIT TO "SUBGROUPS" OUTWEIGHED BY RISK TO ADOLESCENTS
This article was originally published in The Tan Sheet
Executive Summary
OTC ORAL CONTRACEPTIVE BENEFIT TO "SUBGROUPS" OUTWEIGHED BY RISK TO ADOLESCENTS, Tufts University School of Medicine Assistant Professor Ann Davis, MD, maintained during a May 24 conference on Rx-to-OTC switches sponsored by Tufts in Boston. Davis maintained that while moving oral contraceptives over-the-counter "would benefit some subgroups of women, particularly the mature reproductive woman who can understand package directions," ultimately it "would be detrimental to adolescents."
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning